Last $0.10 USD
Change Today 0.00 / 0.00%
Volume 31.3K
ISCO On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 9:50 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Matthias Von Herrath M.D., Ph.D.

Member of Advisory Board, International Stem Cell Corporation
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Matthias Von Herrath, MD, PhD. serves as Member of Advisory Board at International Stem Cell Corporation. Dr. von Herrath is a Professor at the La Jolla Institute of Allergy and Immunology at University of San Diego. He serves as Director of the Center for Type 1 Diabetes Research in addition to being a full Member in the Division of Developmental Immunology. Dr. von Herrath's research focuses on strategies to prevent type 1 diabetes through the induction of regulatory ...

Read Full Background

Corporate Headquarters*

5950 Priestly Drive
Carlsbad, California 92008

United States

Phone: 760-940-6383
Fax: 760-476-0600

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISCO:US $0.10 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Olav Hellebø Chief Executive Officer
ReNeuron Group plc
--
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$406.6K
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Mike Tomas Chief Executive Officer, President, Principal Financial Officer, Principal Accounting Officer, Director and Member of Advisory Board
Bioheart, Inc.
$766.7K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERNATIONAL STEM CELL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.